| Code | 8041D | ||||||||||
| MA number | 57/0196/21-S | ||||||||||
| Product Form: | sol ijf 100x5 ml (amp.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | hameln pharma gmbh, Germany | ||||||||||
| Therapeutic Class: | 57 - HYPNOTICA, SEDATIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous, intramuscular, rectal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.07.2021 |
| Validity: | 30.07.2026 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Midazolam hameln_sol ifj_02_2024.pdf
|
| PIL: |
PIL_Midazolam hameln injekčný_infúzny roztok_01.2025.pdf
|
| Safety feature | Yes |
| Data update: | 02.08.2021 |
